LPM570065, a novel 5-HT/NE/DA triple reuptake inhibitor, can reverse the methylation of gene Oxtr, thus reducing the susceptibility to depression in mice with experience of early life stress. This evidence concerns the gene OXTR and depressive symptom measurement.